rAAV/Her-2/neu loading of dendritic cells for a potent cellular-mediated MHC class I restricted immune response against ovarian cancer

Yuefei Yu, Petra Pilgrim, Wei Zhou, Nicoletta Gagliano, E. Eldo Frezza, Marjorie Jenkins, Jon A. Weidanz, Joseph Lustgarten, Martin Cannon, Klaus Bumm, Everardo Cobos, W. Martin Kast, Maurizio Chiriva-Internati

Research output: Contribution to journalArticle

Abstract

Recent studies demonstrate that recombinant adeno-associated virus (rAAV)-based antigen loading of dendritic cells (DCs) generates, in vitro, significant and rapid cytotoxic T-lymphocyte (CTL) responses against viral antigens. We used the rAAV system to induce specific CTLs against tumor antigens for the development of ovarian cancer (OC) gene therapy. As an extension of the versatility of the rAAV system, we incorporated a self-antigen, Her-2/neu, which is expressed in many cancers, including breast and ovarian. We analyzed two different vectors containing a short (157-612) and long domain (1-1197). Our rAAV vector induced strong stimulation of CTLs directed against the self tumor antigen, Her-2/neu. We then investigated the efficiency of the CTLs in killing Her-2/neu-targeted cells. A significant MHC class I-restricted, anti-Her-2/neu-specific CTL killing was demonstrated against Her-2/neu-positive OC cells after one in vitro stimulation. In summary, single peripheral blood mononuclear cell (PBMC) stimulation with rAAV/157-612- or rAAV/1-1197-pulsed DCs induces strong antigen-specific CTL generation. The CTLs were capable of lysing low doses of peptides pulsed into target cells or OC Her-2/neu+ tumors. These data suggest that AAV-based antigen loading of DCs is highly effective for generating human CTL responses against OC antigens.

Original languageEnglish (US)
Pages (from-to)435-442
Number of pages8
JournalViral Immunology
Volume21
Issue number4
DOIs
StatePublished - Dec 1 2008

    Fingerprint

ASJC Scopus subject areas

  • Immunology
  • Molecular Medicine
  • Virology

Cite this

Yu, Y., Pilgrim, P., Zhou, W., Gagliano, N., Frezza, E. E., Jenkins, M., Weidanz, J. A., Lustgarten, J., Cannon, M., Bumm, K., Cobos, E., Kast, W. M., & Chiriva-Internati, M. (2008). rAAV/Her-2/neu loading of dendritic cells for a potent cellular-mediated MHC class I restricted immune response against ovarian cancer. Viral Immunology, 21(4), 435-442. https://doi.org/10.1089/vim.2008.0029